Margaret Dalesandro - 01 Sep 2023 Form 4 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Margaret Dalesandro
Issuer symbol
N/A
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
4
Filing time
06 Sep 2023, 17:52:23 UTC
Previous filing
29 Aug 2023
Next filing
06 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMAM Ordinary Shares Award $0 +125,000 $0.000000 125,000 01 Sep 2023 Direct F1, F2
transaction AMAM Ordinary Shares Award $0 +70,833 $0.000000 70,833 01 Sep 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares ("ADSs"). Each ADS represents seven (7) Ordinary Shares of the Issuer.
F2 Represents the grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date.
F3 Represents the grant of RSUs payable solely in Ordinary Shares of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date.